Table S1 from Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase–Deficient Renal Cell Carcinoma
Authors:
- Niki M. ZachariasNiki M. Zacharias
- Manuel OzambelaMOManuel Ozambela
- Menuka KarkiMKMenuka Karki
- Rong HeRHRong He
- Pankaj K. ChauhanPCPankaj K. Chauhan
- Pedro I. PesqueraPPPedro I. Pesquera
- Andres E. Hernandez GonzalezAGAndres E. Hernandez Gonzalez
- Oscar OchoaOOOscar Ochoa
- Alberto PierettiAPAlberto Pieretti
- Huiqin ChenHCHuiqin Chen
- Carolyn De La CerdaCCCarolyn De La Cerda
- Zhiyuan YuZYZhiyuan Yu
Open Access
- 3 November 2025
- other
- Published by American Association for Cancer Research (AACR)